Find an Eye MD near you!

Allergan Plc. has purchased AqueSys and its minimally invasive soft shunt for glaucoma, XEN45

Avedro has resubmitted a new drug application for its riboflavin opthalmic solution/KXL system for corneal cross-linking (CXL).

Dr. Sam Masket developed an IOL to prevent negative dysphotopsia, the dark or grey arc-shaped shadow seen in the temporal field of vision following uncomplicated cataract surgery.

The first clinical trial of an extended-release formulation of travoprost shows it’s comparable to topical once-daily travoprost in patients with glaucoma.

Alcon reports that the U.S. FDA has approved its AcrySof IQ aspheric IOL with the UltraSert pre-loaded delivery system.

A complete work-up immediately following nonarteritic central retinal artery occlusion picks up undiagnosed cardiovascular risk factors in almost 80% of patients.


Diagnose This: Minimizing ocular movement during phacoemulsification

◦Attention colleagues! Please reach out to your member of Congress regarding the rising drug prices and lack of tra…

Looks like a great weekend for the WVAEPS 2018 Scientific Conference at the Greenbrier!!! Hope you made your regis…

Suffering eye strain at work? Follow these tips from the American Academy of Ophthalmology to get some relief.